Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
April 13, 2015
Scientists searching for effective treatments for peritoneal mesothelioma are excited about the recent mapping of the genome sequence for the disease. Peritoneal mesothelioma is a fatal cancer of the lining surrounding the abdominal organs. The only confirmed cause of the disease is asbestos exposure.Mesothelioma itself is a rare cancer which strikes 3,000 Americans each year. But most cases of mesothelioma affect the pleura, the lining around the lungs. Only about 10 to 30 percent of mesothelioma cases involve the peritoneum.
Genome sequencing helps scientists understand the molecular mutations that occur in a particular disease. To map the genome, the scientists used cells from two peritoneal mesothelioma patients. The researchers responsible for the promising new development involving peritoneal mesothelioma are from the University of British Columbia, the British Columbia Cancer Agency and Seattle’s PhenoPath Lab.
In the cells of one patient studied, the researchers reportedly found a mutation that was previously unknown. Even though the patient’s cancer had spread to several locations in the body and was of the aggressive sarcomatoid variety, the patient responded favorably to treatment. This could mean that other patients with the same mutation will similarly have a better prognosis with treatment than those who do not have that specific mutation.
It is hoped that having a better understanding of genomics will allow physicians to treat each mesothelioma patient’s disease in a personalized and more effective manner.
If you (or a loved one) have been diagnosed with mesothelioma, contact us by email or call us at 800.226.9880 to speak with our mesothelioma lawyers,Demetrios Zacharopoulos and Anne Izzo in our Maryland office, to learn more about how we can assist you and your family with a mesothelioma lawsuit.
Our Results
Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.
Confidential settlement for the wife of a Rhode Island man who died of mesothelioma cancer after exposure to window glazing compound contaminated with asbestos.